M. Kathleen Behrens, Director at IGM Biosciences, Inc. (IGMS), bought 61,243 shares at $23.00 ($1.4M) on 2022-04-01, disclosed to the SEC on 2022-04-04.
Open-market purchase of $1.4M IGMS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 374 | $0 | 0.0% |
| 2 | $23.00 | 8,695 | $200K | 14.3% |
| 3 | $23.00 | 8,696 | $200K | 14.3% |
| 4 | $23.00 | 43,478 | $1000K | 71.4% |
| Total | $22.86 avg | 61,243 | $1.4M | 100% |
| Filing → |
| SRPT | SELL | 2021-03-10 | $429K | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |
| IGMS | BUY | 2020-09-14 | $3.2M | — | Filing → |